Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation

American Journal of Hematology

Volumn 51, Issue 3, 1996, Pages 186-191

  Okajima, Kenji ^a   Uchiba, Mitsuhiro ^a   Murakami, Kazunori ^a   Okabe, Hiroaki ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Disseminated intravascular coagulation; Hemostatic molecular markers; Hypercoagulable state; Soluble fibrin

Indexed keywords

FIBRIN;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTITHROMBIN III; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTHROMBIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOLUBILITY;

EID: 0029912467     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199603)51:3<186::AID-AJH2>3.0.CO;2-T     Document Type: Article

References (20)

1. Muller-Berghaus G: Pathophysiologic and Biochemical Events in Disseminated Intravascular Coagulation: Dysregulation and Anticoagulant Pathways. Semin Thromb Haemost 15:58, 1989.
2. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic activation. Blood 70:343, 1987.
3. Bone RC: Modulators of coagulation. Arch Intern Med 152:1381, 1992.
4. Godal HC, Abildgaard U: Gelation of soluble fibrin in plasma by ethanol. Scand J Hematol 3:324, 1966.
5. Niewiarowski S, Gurewich V: Laboratory identification of intravascular coagulation: The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J Lab Clin Med 77:665, 1971.
6. Largo R, Heller V, Straub W: Detection of soluble intermediate for the fibrinogen-fibrin monomers. Blood 47:991, 1976.
7. Okajima K, Fujise R, Motosato Y, Ushijima M, Okabe H, Takatsuki K. Plasma levels of granulocyte elastase-1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications Am J Hematol 47.82, 1994.
8. Spero JA, Lewis JH, Hashiba U: Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 43:28, 1980.
9. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59:101, 1988.
10. Pelzer H, Schwarz A, Heimburger N: Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 65:153, 1988
11. Okajima K, Kohno I, Soe G, Okabe H, Takatsuki K, Binder BR: Direct evidence for systemic fibrinogenolysis in patients with acquired alpha-2-plasmin inhibitor deficiency. Am J Hematol 45:10, 1994.
12. Mimuro J, Koike Y, Sumi Y, Aoki N: Monoclonal antibodies to discrete regions in alpha-2-plasmin inhibitor. Blood 69:446, 1987.
13. Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, Draeger B, Naser W, Dessauer A: A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vitro. Blood Coag Fibr 4:97, 1993.
14. Dempfle CE, Dollman M, Lill H, Puzzoivo D, Heene DL: Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to polymerization site "A": Effects of fibrinogen and fibrinogen derivatives, and pretreatment of sample with NaSCN. Blood Coag Fibr 4:79, 1993.
15. Cembrowski GS, Griffin JH, Mosher DF: Diagnostic efficacy of six plasma proteins in evaluating consumptive coagulopathies. Arch Intern Med 146:1997, 1986.
16. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839, 1983.
17. Nieuwenhuizen W: Soluble fibrin as a molecular marker for a prethrombotic state: a mini-review. Blood Coag Fibr 4:93, 1993.
18. Dvorak HF, Senger DR, Dvorak AM: Fibrin as a component of the tumor stroma: Origins and biological significance. Cancer Metastasis Rev 2:41, 1983.
19. Kruitof EKO, Gundinchet A, Bachman F: Plasminogen activator inhibitor-1 and plasminogen activator inhibitor-2 in various disease states. Thromb Haemost 59:7, 1988.
20. 2-Antiplasmin inhibitor is among acute phase reactants. Thromb Res 17:527, 1980.